Valuation (43%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 47.60 | N/A |
| PEG Ratio (TTM) | 18.32 | N/A |
| P/S Ratio (TTM) | 1.45 | N/A |
| P/B Ratio (TTM) | 3.34 | N/A |
| P/FCF Ratio (TTM) | 18.38 | N/A |
| Price to 5YR AVG Earnings Ratio | -304.88 | N/A |
| Price to 5YR AVG FCF Ratio | 37.36 | N/A |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.52% | N/A |
| ROE (TTM) | 7.58% | N/A |
| Net Profit Margin (TTM) | 3.01% | N/A |
| ROIC 5YR AVG | 2.94% | N/A |
Growth (68%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 12.59% | -17.53% | -67.43% |
| Revenue | 0.81% | 66.81% | 54.50% |
| Net Income | 19.91% | -27.26% | 16.63% |
| Cash Flow | 395.01% | 67.10% | 68.00% |
Health (47%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.51 | N/A |
| Quick Ratio (TTM) | 1.42 | N/A |
| D/E Ratio (TTM) | 0.96 | N/A |
| Interest Coverage (TTM) | 3.15 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 2.31 | N/A |
| LTL to 5YR AVG FCF | 9.29 | N/A |
| Shares Outstanding Growth 5YR AVG | 16.39% | N/A |